Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease

Transglutaminase Type II Is Involved in the Pathogenesis of Endotoxic Shock

(2014) L. Falasca et al.   JOURNAL OF IMMUNOLOGY

Glutamine Prevents Fibrosis Development in Rats with Colitis Induced by 2,4,6-Trinitrobenzene Sulfonic Acid

(2010) Beatriz San-Miguel et al.   JOURNAL OF NUTRITION

Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line

(2010) Leda Roncoroni et al.   LIVER INTERNATIONAL

Sulfur Metabolism in AIDS: Cystamine as an Anti-HIV Agent

(2009) John I. Toohey   AIDS RESEARCH AND HUMAN RETROVIRUSES

Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver

(2009) L. Elli et al.   DIGESTIVE AND LIVER DISEASE

Biological Therapies for Inflammatory Bowel Diseases

(2009) Paul Rutgeerts et al.   GASTROENTEROLOGY

Transglutaminases and neurodegeneration

(2009) Thomas M. Jeitner et al.   JOURNAL OF NEUROCHEMISTRY

Do we really understand what the immunological disturbances in inflammatory bowel disease mean?

(2009) Epameinondas V Tsianos et al.   WORLD JOURNAL OF GASTROENTEROLOGY

An overview of the first 50 years of transglutaminase research

(2008) Simone Beninati et al.   AMINO ACIDS

Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications

(2008) R. J. Collighan et al.   AMINO ACIDS

Novel therapeutic options in the inflammatory bowel disease world

(2007) A. Noble et al.   DIGESTIVE AND LIVER DISEASE